Study Reveals Weakness in Rare Ovarian Cancer Tumors That May Lead to Improved Treatment Options
May 24, 2025
May 24, 2025
PHOENIX, Arizona, May 24 (TNSrep) -- The Translational Genomics Research Institute issued the following news release:
* * *
Study reveals weakness in rare ovarian cancer tumors that may lead to improved treatment options
Findings could suggest new targets for immunotherapy
A recent study led by researchers at TGen, part of City of Hope, has revealed that dysfunctional gene splicing in a rare type of ovarian cancer may increase the likelihood of . . .
* * *
Study reveals weakness in rare ovarian cancer tumors that may lead to improved treatment options
Findings could suggest new targets for immunotherapy
A recent study led by researchers at TGen, part of City of Hope, has revealed that dysfunctional gene splicing in a rare type of ovarian cancer may increase the likelihood of . . .